Rating History for Sigilon Therapeutics (SGTX) by BTIG

More Stocks Rated by BTIG | Latest Ratings for SGTX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/30/2023 Thomas Shrader Downgrade Neutral
(Buy)		 N/A
(N/A)		 3.93
(22.47)		 471.76% Details